Examine This Report on what kind of drug is nembutal
Examine This Report on what kind of drug is nembutal
Blog Article
pentobarbital will lessen the level or effect of zolpidem by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unknown.
pentobarbital increases toxicity of ifosfamide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of. CYP3A4 inducers may boost the metabolism of ifosfamide to its active alkylating metabolites.
pentobarbital will decrease the level or result of cariprazine by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lower the level or impact of bedaquiline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Stay away from coadministration of bedaquiline with potent CYP3A4 inducers resulting from opportunity for decreased therapeutic outcome
pentobarbital will lower the extent or effect of cilostazol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital will lower the level or outcome of iloperidone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will lessen the extent or outcome of doxorubicin liposomal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital will lessen the level or impact of lumacaftor/ivacaftor by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
pentobarbital improves toxicity of ifosfamide by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of. CYP3A4 inducers may perhaps increase the metabolism of ifosfamide to its Energetic alkylating metabolites.
pentobarbital will decrease the extent or influence of atorvastatin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
pentobarbital will lower the level or impact of pazopanib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital will minimize the level or effect of repaglinide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
Keep away from; coadministration with CYP3A inducers may possibly cause decreased plasma concentrations of elvitegravir and/or maybe a concomitantly administered protease inhibitor and bring on loss of therapeutic effect and also to achievable resistance
pentobarbital will lower the level or influence of check here lefamulin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Stay away from coadministration of lefamulin with sturdy or average CYP3A inducers Until the profit outweighs risks. Check for diminished efficacy.